Brent Berry
Neurology · Golden Valley, MNNPI 1013263011
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $113,235 of the $140,537 with a category attached, or 80.6%. Eisai Inc. accounts for 70.6% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $121,683, more than ten times the $216 reported in 2023. Among neurology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $644.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$99K
- Lilly USA, LLC$41K
- W. L. Gore & Associates, Inc.$128
- Takeda Pharmaceuticals U.S.A., Inc.$59
- Teva Pharmaceuticals USA, Inc.$45
- UCB, Inc.$33
- plus $249 from 13 others
What the payments were for
- Consulting fees$4,6903%
- Speaking & faculty fees$113,23581%
- Travel & lodging$19,33214%
- Food & beverage$3,2802%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 150 | $99,211 |
| Lilly USA, LLC | 44 | $40,812 |
| W. L. Gore & Associates, Inc. | 1 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| UCB, Inc. | 2 | $33 |
| AstraZeneca | 2 | $31 |
| Neurelis, Inc. | 2 | $29 |
| Novartis | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Corium, LLC | 1 | $18 |
| Octapharma USA, Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Argenx US, Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| AbbVie | 1 | $14 |
| Catalyst Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Leqembi$96,024
- KISUNLA$35,824
- GORE CARDIOFORM Septal Occluder$128
How this compares
$140,537 in reported general payments places this provider in the 95th percentile of 434 neurology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 65 | $2,534 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 90 | $2,121 |
| Lamotrigine | 25 | $1,026 |
| Gabapentin | 28 | $894 |
| Donepezil Hcl | 39 | $625 |
| Levetiracetam ErLevetiracetam | 14 | $567 |
| Pregabalin | 12 | $240 |
| Topiramate | 14 | $212 |
| Sumatriptan Succinate | 11 | $150 |
| Tizanidine Hcl | 15 | $114 |
| Risperidone | 12 | $52 |
| Lorazepam | 14 | $20 |
Paid to pharmacies, not to this prescriber.
Other neurology in Golden Valley
- Jonathan CalkwoodGolden Valley$493K
- Irfan AltafullahGolden Valley$203K
- Jessica StulcGolden Valley$199K
- Akram DastagirGolden Valley$174K
- Jessica HeiringGolden Valley$149K
- Joanne RoginGolden Valley$61K
- Xiaoming DongGolden Valley$47K
- Randall SchapiroGolden Valley$19K
- Jeffery AllenMinneapolis$1.1M
- Alejandro RabinsteinRochester$305K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.